Thirty patients were admitted to the study, all of whom fitted CDC criteria for diagnosis.
recordings of each pair were acquired and stored in this way. At least 10 potential pairs were analysed. The recording was made with voluntary activation of the muscle, with the subject maintaining a slight, steady contraction.
The interpotential interval (IPI) and mean consecutive differences (MCD) were calculated. Thirty age and sex matched control subjects were studied in parallel. The mean age of the patient group was 39 (range 21 to 58) years and the mean age of the control group was 34 (range 21 to 55) years.
Results
The mean MCD of the controls was 25-7 (SD 4-3) ps. The jitter was considered abnormal if it was greater than 3 SD above the control mean, or if more than two pairs had jitter in excess of 55 ps or if blocking was seen. Using these criteria five subjects with chronic fatigue syndrome had abnormal jitter. Blocking was seen in only two patients. One of these had 5% blocking in only 1/10 pairs studied and the mean jitter was increased (50 3 ps). The other had 5% blocking in 2/10 pairs and the mean jitter was 493 pus. Three other subjects with chronic fatigue syndrome had abnormal jitter (each with 2/10 pairs greater than 55 us, the mean jitter being 33 
and the remaining 25 patients (p < 0 001, Student's t test). There was also a very small but significant difference between the control group and the 25 patients with normal results (p < 0 05, Student's t test). The MCD values did not correlate with the duration of illness, different clinical phenotypes, or history of an infectious disease at the onset. The interpotential intervals were recorded but are not reported here. They were all less than 2-5 ms and there was no significant difference between the control or either patient groups.
Discussion
This study has shown a small subgroup of patients with chronic fatigue syndrome who have abnormal single fibre jitter without any other evidence of motor unit abnormality. All of our patients with abnormal jitter had variable innervation rates associated with abnormal recruitment of motor units, which is a common finding in chronic fatigue syndromes. This finding was also common among the other patients. There was a slightly higher jitter in the patient v the control group. The amount of this difference is very small and not clinically important. Fatigue due to neuromuscular transmission defects depends upon the presence of blocking and this was not present in most patients.
The reasons for the discrepancy between our findings and those of Jamal and Hansen," who found 75% of their patients had abnormal studies, is not clear. Comparison of data of this type with an age and sex matched control group, as in this study, rather than with standard laboratory reference ranges, is clearly essential, however.
Variability in jitter is usually due largely to neuromuscular transmission at the motor end plates. Variability of conduction in the terminal axon branches or variability of muscle fibre propagation may also contribute significantly to jitter.'2 Trontelj et al13 have shown that the contribution to jitter from muscle fibre propagation (myogenic jitter) is normally small and with more or less constant rates of stimulation of axons, is less than 5 ,us. Increased myogenic jitter can potentially be produced, however, by long mean interpotential intervals and with erratic discharge rates. 13 In this study all interpotential intervals recorded were less than 2-5 ms and therefore variability in the interpotential intervals is not likely to be an important factor. Direct stimulation of muscle fibres and stimulated SFEMG studies would eliminate the contribution of the effects of variation in rates of transmission in the axons and across the neuromuscular synapses and may help localise the site of origin of the abnormal jitter. The cause of the blocking seen in two patients is not clear. This was, however, only a minor finding present in very few pairs and it is probably of no clinical importance.
Conclusion
In this study only five out of 30 patients with chronic fatigue syndrome had an abnormal jitter and the mean of the jitter in the remaining patients was only slightly higher than in the controls. These abnormalities are considerably less than in a previously reported study. It is suggested that the increased jitter may be explained by variable rates of innervation producing an unusually large component of myogenic jitter rather than being related to primary effects of the disorder at the neuromuscular junction, terminal axon, or muscle membrane. The low incidence of abnormal studies and the minor abnormalities seen suggest that the increased jitter is not due to an important pathogenetic factor in chronic fatigue syndrome. In our hands, SFEMG is not a useful test in chronic fatigue syndrome, other than to exclude other conditions such as myasthenia gravis.
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